Our Science

Sort

EGFR Targeting

mAbs

Learn about Merck’s research into the monoclonal antibody, cetuximab, that induces tumor cell death by blocking the epidermal growth factor receptor (EGFR) and disrupting
EGFR signaling

10 Min

GL-MULO-00228 | December 2025